Literature DB >> 8770353

Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection.

S M Crowe1.   

Abstract

There are a number of machanisms by which HIV-infected macrophages contribute to the pathogenesis of the Acquired Immunodeficiency Syndrome (AIDS). Macrophage-tropic strains of HIV are present at the time of infection, and persist throughout the course of infection, despite the emergence of T cell tropic quasispecies. As HIV causes chronic infection of macrophages with only minimal cytopathology, these cells can provide an important viral reservoir in HIV-infected persons. Macrophages are more susceptible to HIV infection than freshly isolated monocytes. HIV-infected macrophages can contribute to CD4 T lymphocyte depletion through a gp120-CD4 dependent fusion process with uninfected CD4-expressing T cells. Increasing data support the role of HIV-infected macrophages and microglia in the pathogenesis of HIV-related encephalopathy and AIDS-related dementia through the production of neurotoxins. HIV infection of macrophages in vitro results in impairment of many aspects of their function. Reduced phagocytic capacity for certain opportunistic pathogens, including Toxoplasma gondii and Candida albicans, may be responsible for reactivation of these pathogens in persons with advanced HIV infection, although the mechanisms underlying reactivation of infections and susceptibility to disease from new infections are likely to be multifactorial. Our studies showing defective phagocytosis and killing provide additional information that contribute to our understanding of the pathogenesis of AIDS. Studies of in vitro efficacy of potential antiretroviral therapies should be performed in both primary lymphocyte and monocyte cultures, given the importance of both of these cell populations to HIV pathogenesis and their differing biology.

Entities:  

Mesh:

Year:  1995        PMID: 8770353     DOI: 10.1111/j.1445-5994.1995.tb02881.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  18 in total

1.  Down regulation of CD4 expression following isolation and culture of human monocytes.

Authors:  G M Graziani-Bowering; L G Filion
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Authors:  Anne-Sophie Dugast; Andrew Tonelli; Christoph T Berger; Margaret E Ackerman; Gaia Sciaranghella; Qingquan Liu; Magdalena Sips; Ildiko Toth; Alicja Piechocka-Trocha; Musie Ghebremichael; Galit Alter
Journal:  Virology       Date:  2011-05-12       Impact factor: 3.616

4.  Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages.

Authors:  Shuzhen Chen; Daniel L Tuttle; Joseph T Oshier; Harm J Knot; Wolfgang J Streit; Maureen M Goodenow; Jeffrey K Harrison
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

5.  Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons.

Authors:  Kathleen Borgmann; Kavitha S Rao; Vinod Labhasetwar; Anuja Ghorpade
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-02       Impact factor: 2.205

6.  Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS.

Authors:  S P Raffanti; W Schaffner; C F Federspiel; R B Blackwell; O A Ching; F W Kühne
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

Review 7.  HIV-1 gp120 chemokine receptor-mediated signaling in human macrophages.

Authors:  Bruce D Freedman; Qing-Hua Liu; Manuela Del Corno; Ronald G Collman
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 8.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

9.  The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV.

Authors:  D Wodarz; M A Nowak
Journal:  Proc Biol Sci       Date:  1998-11-22       Impact factor: 5.349

10.  Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Dafna Bonneh-Barkay; Adam Starkey; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.